Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

COVID-19 Recovery Analysis: Monoclonal Antibodies Market | Advent of Low-priced Biosimilar Monoclonal Antibodies to Boost the Market Growth | Technavio

share with twitter share with LinkedIn share with facebook
09/18/2020 | 09:16pm EDT

Technavio has been monitoring the monoclonal antibodies market and it is poised to grow by $ 54.55 bn during 2020-2024, progressing at a CAGR of over 7% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200918005327/en/

Technavio has announced its latest market research report titled Global Monoclonal Antibodies Market 2020-2024 (Graphic: Business Wire)

Technavio has announced its latest market research report titled Global Monoclonal Antibodies Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

The market is concentrated, and the degree of concentration will accelerate during the forecast period. AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Advent of low-priced biosimilar monoclonal antibodies has been instrumental in driving the growth of the market. However, the high cost of monoclonal antibodies might hamper the market growth.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Monoclonal Antibodies Market 2020-2024: Segmentation

Monoclonal Antibodies Market is segmented as below:

  • Application
    • Oncology
    • Autoimmune Disorders
    • Infectious Diseases
    • Other Applications
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

Monoclonal Antibodies Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The monoclonal antibodies market report covers the following areas:

  • Monoclonal Antibodies Market Size
  • Monoclonal Antibodies Market Trends
  • Monoclonal Antibodies Market Industry Analysis

This study identifies a strong R&D pipeline as one of the prime reasons driving the monoclonal antibodies market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Monoclonal Antibodies Market 2020-2024: Key Highlights

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will assist monoclonal antibodies market growth during the next five years
  • Estimation of the monoclonal antibodies market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the monoclonal antibodies market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of monoclonal antibodies market, vendors

Table of Contents:

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Oncology - Market size and forecast 2019-2024
  • Autoimmune disorders - Market size and forecast 2019-2024
  • Infectious diseases - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by Application

Market Segmentation by Type

  • Segmentation by type of monoclonal antibodies

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive Scenario
  • Vendor Landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi


  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

© Business Wire 2020

share with twitter share with LinkedIn share with facebook
Latest news "Companies"
02:40aTRANSGENE : October 27, 2020 - Transgene announces detailed results from clinical study of TG4001 in combination with avelumab in advanced HPV-positive cancers
02:40aRESURS : Interim Report January - September 2020
02:40aFLAGSHIP INVESTMENTS : Results of the Annual General Meeting – October 2020
02:38aURGENT : ANA expects record net loss of 510 bil. yen in FY 2020 amid pandemic
02:37aNOVARTIS : third-quarter core net income rises to $3.47 billion
02:36aNORWAY ROYAL SALMON (NRS) : Invitation to Webcast of Q3 2020 on 3 November 2020 at 8:00 am (CET)
02:36aSPAREBANK 1 SR-BANK ASA (SRBANK) : Reminder - Presentation of third quarter 2020 accounts
02:36aSAP SE : Credit Suisse maintains a Buy rating
02:36aSPAREBANK 1 SR-BANK ASA (SRBANK) : Reminder - Presentation of third quarter 2020 accounts
02:35aAMS : launches offering by way of private placement of approx. EUR 750 million convertible bonds due 2027 ...
Latest news "Companies"